Telormedix's Grant - II Round

Telormedix raised a round of funding on August 08, 2013. Investors include Eurostars Programme.

Telormedix is a biopharmaceutical company focused on targeted immunity and modulation of the innate immune system for treating cancer and autoimmune diseases. The Company's lead product, TMX-101, is c…

Articles about Telormedix's Grant - II Round: